Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Tianjin Pharmaceutical Da Ren Tang Group Corporation (600329)
- 42.03
- +0.18+0.43%
Market Closed May 7 15:00 CST
32.37BMarket Cap14.84P/E (TTM)
42.22High41.55Low36.68KlotVolume41.86Open41.85Prev Close153.67MTurnover0.65%Turnover Ratio15.19P/E (Static)770.09MShares48.5252wk High4.30P/B23.83BFloat Cap25.8952wk Low46.04Limit Up567.09MShs Float50.13Historical High37.67Limit Down1.60%Range %-6.78Historical Low3.73Dividend TTM41.89Avg Price15.98KlotAsk8.87%Div Yield TTM100Lot Size20.14KlotBid
Tianjin Pharmaceutical Da Ren Tang Group Corporation (600329) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -37.98%902.12M | -65.48%1.02B | -27.91%1.05B | 5.01%3.63B | -40.81%1.45B | 38.55%2.94B | -27.98%1.45B | 64.17%3.45B | -28.87%2.46B | -26.27%2.13B |
| Notes receivable and accounts receivable | 14.76%1.4B | 28.57%1.17B | -50.14%1.19B | -49.72%1.31B | -53.28%1.22B | -59.14%909.28M | -9.09%2.38B | 2.46%2.6B | 4.93%2.62B | -0.87%2.23B |
| -Notes receivable | -9.70%124.33M | 28.04%195.89M | 2,062.64%158.98M | 12,157.81%80.95M | 340.11%137.69M | 191.99%152.99M | -62.00%7.35M | -96.89%660.4K | -43.03%31.29M | -46.70%52.39M |
| -Accounts receivable | 17.86%1.28B | 28.68%973.2M | -56.69%1.03B | -52.82%1.23B | -58.03%1.09B | -65.19%756.29M | -8.69%2.37B | 3.30%2.6B | 6.01%2.59B | 1.23%2.17B |
| Other receivables (including interest and dividends) | 26.04%10.58M | 10.55%9.43M | -93.90%11.79M | -63.33%15.54M | -84.19%8.39M | -74.79%8.53M | 643.96%193.38M | 65.43%42.37M | 42.00%53.08M | -44.09%33.85M |
| -Dividend receivable | ---- | ---- | ---- | --2.4M | ---- | ---- | --179.87M | ---- | ---- | ---- |
| -Accrued interest receivable | --3.02M | --3.02M | --3.02M | --3.02M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | ---- | ---- | ---- | -76.11%10.12M | ---- | -74.79%8.53M | ---- | 65.43%42.37M | ---- | -44.09%33.85M |
| Advance payment | 83.54%28.52M | 29.89%32.91M | 19.80%75.38M | -86.95%10.84M | -73.88%15.54M | -66.54%25.34M | -25.19%62.92M | 21.70%83.05M | -35.06%59.48M | 5.86%75.72M |
| Inventories | -10.55%1.08B | -11.88%1.13B | -26.09%1.21B | -21.40%1.22B | -18.77%1.2B | -17.93%1.29B | -2.62%1.63B | -7.32%1.55B | 1.35%1.48B | 9.59%1.57B |
| Receivable financing | -15.55%393.37M | -1.19%402.22M | 30.06%437.63M | 37.04%473.64M | -29.22%465.77M | -4.89%407.08M | 56.62%336.47M | 19.75%345.62M | 134.06%658.02M | -10.85%427.99M |
| Non-current assets due within one year | 3,815.57%865.68M | 3,046.85%690.21M | 1,509.68%685.28M | 1,361.49%617.5M | -46.95%22.11M | -47.01%21.93M | 103.97%42.57M | 103.86%42.25M | --41.67M | --41.39M |
| Other current assets | 10.14%1.43B | 168.57%2.7B | 126.71%2.32B | 1,792.28%876.96M | 2,480.84%1.3B | 1,698.68%1.01B | 1,950.73%1.02B | -35.44%46.34M | -36.56%50.44M | -27.21%55.92M |
| Total current assets | 7.36%6.12B | 8.27%7.15B | -2.18%6.97B | -0.21%8.15B | -23.25%5.7B | 0.86%6.61B | 6.18%7.12B | 20.23%8.17B | -6.10%7.42B | -9.58%6.55B |
| Non Current assets | ||||||||||
| Other equity investment | ---- | ---- | ---- | ---- | -85.05%50.91K | -74.94%91.86K | -26.82%233.55K | -26.82%233.55K | 6.10%340.57K | 14.18%366.51K |
| Investment real estate | 892.01%109.35M | 878.54%110.37M | 811.17%111.4M | -13.81%10.77M | -13.62%11.02M | -13.43%11.28M | -8.05%12.23M | -7.89%12.49M | -7.74%12.76M | -7.59%13.03M |
| Long-term equity investment | -10.98%1.17B | -9.89%1.17B | 27.37%1.18B | 44.26%1.2B | 68.06%1.32B | 46.61%1.29B | 16.92%929.65M | -2.12%831.59M | 3.91%783.25M | 16.06%882.31M |
| Fixed assets | ---- | ---- | ---- | -15.23%871.19M | ---- | -9.33%950.45M | ---- | -5.24%1.03B | ---- | -7.05%1.05B |
| Constru in process | ---- | ---- | ---- | 6.47%456.62M | ---- | 12.91%436.35M | ---- | 23.99%428.88M | ---- | 15.76%386.46M |
| Intangible assets | -0.69%288.69M | -0.86%292.75M | -10.57%272.85M | -7.42%286.13M | -7.10%290.69M | -7.07%295.29M | -6.14%305.1M | -6.29%309.07M | -5.79%312.9M | 13.03%317.75M |
| Development expenditure | -56.47%18.49M | -56.54%18.39M | --42.95M | 225.96%42.62M | 224.90%42.48M | 223.69%42.33M | ---- | 1.17%13.08M | 18.85%13.08M | 18.85%13.08M |
| Goodwill | ---- | ---- | -81.34%12.3M | -81.34%12.3M | -81.34%12.3M | -81.34%12.3M | -22.18%65.91M | -22.18%65.91M | -22.18%65.91M | -22.18%65.91M |
| Long deferred expense | 60.72%38.53M | 45.03%34.44M | 206.24%19.51M | 328.53%21.17M | 402.13%23.98M | 354.67%23.74M | 24.78%6.37M | -11.43%4.94M | -20.43%4.77M | -20.10%5.22M |
| Deferred tax assets | 8.48%368.27M | 8.46%341.01M | 5.80%319.35M | 5.69%337.41M | 17.86%339.49M | 18.20%314.4M | 27.86%301.86M | 32.76%319.25M | 22.90%288.06M | 27.66%265.99M |
| Usufruct assets | 82.93%11.06M | 13.59%7.55M | 27.29%5.1M | 19.04%5.63M | 8.16%6.05M | -1.83%6.65M | 167.14%4.01M | 143.84%4.73M | 127.76%5.59M | 126.05%6.77M |
| Other non current assets | -41.97%1.19B | 84.85%1.43B | 84.57%1.43B | 103.92%1.46B | 205.47%2.06B | 14.99%774.15M | 1,808.78%772.64M | 1,732.23%715.79M | 1,658.20%673.27M | 1,596.98%673.26M |
| Total non current assets | -21.05%4.32B | 9.00%4.54B | 20.04%4.62B | 25.96%4.7B | 50.78%5.47B | 13.11%4.16B | 7.65%3.85B | 4.56%3.73B | 22.48%3.63B | 26.34%3.68B |
| Total assets | -6.56%10.44B | 8.55%11.69B | 5.61%11.59B | 8.00%12.85B | 1.06%11.17B | 5.26%10.77B | 6.69%10.97B | 14.83%11.9B | 1.69%11.05B | 0.72%10.23B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -34.34%47.56M | 167.41%57.9M | -98.55%14.88M | -99.13%6.97M | -81.03%72.43M | -73.53%21.65M | 93.01%1.02B | 51.31%802.2M | 8.69%381.8M | -19.52%81.8M |
| Notes payable and accounts payable | -9.90%238.1M | -23.36%218.05M | -79.82%200.12M | -79.36%219.73M | -76.40%264.27M | -74.73%284.51M | -1.62%991.88M | -5.59%1.06B | -12.61%1.12B | -19.90%1.13B |
| -Notes payable | ---- | ---- | ---- | ---- | ---- | ---- | -6.67%377.99M | -17.87%362.34M | -16.32%497.53M | -25.07%510.71M |
| -Accounts payable | -9.90%238.1M | -23.36%218.05M | -67.40%200.12M | -68.71%219.73M | -57.53%264.27M | -53.77%284.51M | 1.77%613.89M | 2.30%702.22M | -9.40%622.2M | -15.04%615.38M |
| Contract liabilities | 6.17%100.6M | 20.61%148.53M | 20.51%76.53M | -25.77%110.91M | -23.76%94.76M | -15.46%123.14M | -46.24%63.51M | 20.14%149.42M | -2.96%124.28M | -33.51%145.66M |
| Advance receipts | 1,125.81%1.37M | 296.81%1.66M | --105K | --103.6K | --111.9K | --418.24K | ---- | ---- | ---- | ---- |
| Salaries payable | -12.66%234M | -16.67%225.05M | -10.65%267.85M | -15.28%282.52M | -1.41%267.91M | 7.42%270.09M | 42.77%299.78M | 21.60%333.47M | 15.10%271.74M | 22.02%251.44M |
| Taxs payable | 9.83%213.1M | -65.44%115.93M | -21.45%123.05M | 114.33%405.26M | 9.35%194.03M | 117.44%335.48M | 13.17%156.64M | 30.39%189.08M | -17.35%177.43M | -21.63%154.28M |
| Other payable (including interest and dividends) | 1.98%1.95B | 114.45%3.68B | 10.73%1.78B | 9.07%2.91B | 20.84%1.91B | 19.08%1.72B | 15.58%1.61B | 93.14%2.67B | 17.29%1.58B | 20.22%1.44B |
| -Interest payable | -0.00%975.07K | 9.28%975.07K | -74.00%975.07K | -46.08%975.07K | -66.37%975.07K | 1.49%892.26K | 75.24%3.75M | 218.26%1.81M | 87.73%2.9M | 243.18%879.15K |
| -Dividend payable | 52.68%40.66M | 7,102.14%1.92B | 17.78%31.49M | 0.46%1.01B | 21.79%26.63M | 21.79%26.63M | 22.25%26.73M | 4,508.15%1.01B | 24.27%21.87M | 24.27%21.87M |
| -Other payable | 1.26%1.91B | 4.38%1.76B | 10.81%1.75B | 14.36%1.9B | 20.99%1.88B | 19.05%1.69B | 15.38%1.58B | 22.12%1.66B | 17.12%1.56B | 20.11%1.42B |
| Non current liabilities due within one year | 106.29%4.38M | 135.08%3.12M | -95.86%1.74M | -93.07%1.81M | -31.37%2.12M | -62.71%1.33M | 4,819.07%42.04M | -10.32%26.19M | 136.87%3.09M | -13.00%3.56M |
| Other current liabilities | 1.45%41.57M | -16.55%53.28M | 72.55%12M | -2.49%13.98M | 221.98%40.98M | 128.83%63.85M | 0.50%6.95M | --14.33M | --12.73M | 16,065.76%27.9M |
| Total current liabilities | -0.64%2.83B | 59.93%4.51B | -40.92%2.48B | -24.68%3.95B | -22.46%2.85B | -12.84%2.82B | 23.16%4.19B | 45.29%5.25B | 3.12%3.67B | -3.02%3.23B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | -10.97%214.97M | -3.81%232.25M | -4.93%241.03M | 59.31%241.03M |
| Long term account payable | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Long term salaries pay | -32.20%2.4M | -32.20%2.4M | -55.15%3.54M | -55.42%3.54M | -56.58%3.54M | -56.58%3.54M | -21.82%7.89M | -21.33%7.94M | -19.24%8.15M | -19.24%8.15M |
| Specific account payable | ---- | ---- | ---- | -14.09%30.53M | ---- | -14.09%30.53M | ---- | -3.13%35.54M | ---- | -3.13%35.54M |
| Deferred tax liabilities | -95.76%242.85K | -95.42%276.26K | -27.08%5.12M | -19.21%5.43M | -24.95%5.73M | -17.66%6.04M | -7.16%7.03M | -14.70%6.72M | -13.36%7.64M | -16.84%7.33M |
| Long term deferred income | -17.18%45.48M | -17.51%45.49M | -26.03%41.39M | -2.35%54.51M | -2.47%54.91M | -3.51%55.14M | -9.12%55.96M | -7.52%55.82M | -5.25%56.31M | -4.56%57.14M |
| Lease liabilities | 36.52%5.91M | -16.87%4.66M | 68.91%3.93M | 95.06%3.96M | 87.79%4.33M | 104.29%5.6M | 289.85%2.33M | 233.51%2.03M | 295.99%2.3M | 214.73%2.74M |
| Total non current liabilities | -14.62%84.56M | -17.35%83.35M | -73.89%84.51M | -71.21%97.96M | -71.78%99.04M | -71.34%100.85M | -10.27%323.71M | -5.74%340.3M | -5.93%350.97M | 29.58%351.94M |
| Total liabilities | -1.11%2.91B | 57.26%4.59B | -43.28%2.56B | -27.51%4.05B | -26.76%2.95B | -18.58%2.92B | 19.95%4.52B | 40.66%5.59B | 2.26%4.02B | -0.56%3.58B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%770.09M | 0.00%770.09M | -0.01%770.09M | -0.01%770.09M | -0.01%770.09M | -0.01%770.09M | -0.01%770.16M | -0.01%770.16M | -0.42%770.16M | -0.42%770.16M |
| Capital reserve funds | 0.02%974.98M | 0.02%974.98M | -0.06%974.98M | -0.06%974.98M | -0.06%974.79M | -0.04%974.79M | -0.01%975.57M | 0.05%975.56M | -5.05%975.38M | -6.93%975.21M |
| Surplus reserve funds | 0.00%436.75M | 0.00%436.75M | 0.00%436.75M | 0.00%436.75M | 0.00%436.75M | 0.00%436.75M | 0.00%436.75M | 0.00%436.75M | 0.00%436.75M | 0.00%436.75M |
| Retained profit | -11.51%5.32B | -13.16%4.89B | 61.58%6.8B | 61.87%6.58B | 25.75%6.01B | 28.32%5.64B | -1.25%4.21B | -1.54%4.06B | 2.37%4.78B | 2.99%4.39B |
| Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | ---- | -28.05%5.39M | -28.05%5.39M | -76.35%7.04M | -76.35%7.04M |
| Other composite income | -13.69%23.15M | -10.62%24.07M | -22.67%26.03M | -19.61%26.17M | -19.40%26.82M | -21.57%26.93M | 10.83%33.66M | 5.35%32.56M | 12.28%33.27M | 16.27%34.34M |
| Shareholders equity without minority interests | -8.46%7.52B | -9.49%7.1B | 40.33%9.01B | 40.05%8.78B | 17.61%8.22B | 18.83%7.84B | -0.74%6.42B | -0.94%6.27B | 1.19%6.99B | 1.21%6.6B |
| Minority interests | -107.44%-288.85K | -92.97%445.7K | -56.38%14.75M | -57.40%16.19M | -90.44%3.88M | -85.76%6.34M | -31.24%33.82M | -33.72%38M | 47.71%40.6M | 46.09%44.55M |
| Total shareholder equity | -8.51%7.52B | -9.55%7.1B | 39.82%9.02B | 39.46%8.8B | 16.99%8.22B | 18.13%7.85B | -0.97%6.45B | -1.23%6.31B | 1.37%7.03B | 1.42%6.65B |
| Total liabilityies and equity | -6.56%10.44B | 8.55%11.69B | 5.61%11.59B | 8.00%12.85B | 1.06%11.17B | 5.26%10.77B | 6.69%10.97B | 14.83%11.9B | 1.69%11.05B | 0.72%10.23B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Zhongshenhua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongshenhua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongshenhua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm